215 related articles for article (PubMed ID: 26018236)
1. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis.
Chai-Adisaksopha C; Hillis C; Monreal M; Witt DM; Crowther M
Thromb Haemost; 2015 Oct; 114(4):819-25. PubMed ID: 26018236
[TBL] [Abstract][Full Text] [Related]
2. Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis.
Majeed A; Wallvik N; Eriksson J; Höijer J; Bottai M; Holmström M; Schulman S
Thromb Haemost; 2017 Feb; 117(3):491-499. PubMed ID: 28004062
[TBL] [Abstract][Full Text] [Related]
3. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis.
Tapaskar N; Pang A; Werner DA; Sengupta N
Dig Dis Sci; 2021 Feb; 66(2):554-566. PubMed ID: 32279174
[TBL] [Abstract][Full Text] [Related]
4. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.
Zhou Z; Yu J; Carcel C; Delcourt C; Shan J; Lindley RI; Neal B; Anderson CS; Hackett ML
BMJ Open; 2018 May; 8(5):e019672. PubMed ID: 29764874
[TBL] [Abstract][Full Text] [Related]
5. Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis.
Little D; Chai-Adisaksopha C; Hillis C; Witt DM; Monreal M; Crowther MA; Siegal DM
Thromb Res; 2019 Mar; 175():102-109. PubMed ID: 30743134
[TBL] [Abstract][Full Text] [Related]
6. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
[TBL] [Abstract][Full Text] [Related]
8. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants.
Caldeira D; Barra M; Ferreira A; Rocha A; Augusto A; Pinto FJ; Costa J; Ferreira JJ
Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1239-49. PubMed ID: 26434935
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.
Sherwood MW; Nessel CC; Hellkamp AS; Mahaffey KW; Piccini JP; Suh EY; Becker RC; Singer DE; Halperin JL; Hankey GJ; Berkowitz SD; Fox KAA; Patel MR
J Am Coll Cardiol; 2015 Dec; 66(21):2271-2281. PubMed ID: 26610874
[TBL] [Abstract][Full Text] [Related]
11. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
[TBL] [Abstract][Full Text] [Related]
12. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
[TBL] [Abstract][Full Text] [Related]
13. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation.
Candeloro M; van Es N; Cantor N; Schulman S; Carrier M; Ageno W; Aibar J; Donadini MP; Bavalia R; Arsenault MP; Coppens M; Ferrante N; D'Addezio A; Sormani S; Porreca E; Di Nisio M
J Thromb Haemost; 2021 Oct; 19(10):2618-2628. PubMed ID: 34318606
[TBL] [Abstract][Full Text] [Related]
14. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding.
Little DHW; Sutradhar R; Cerasuolo JO; Perez R; Douketis J; Holbrook A; Paterson JM; Gomes T; Siegal DM
CMAJ; 2021 Mar; 193(9):E304-E309. PubMed ID: 33649169
[TBL] [Abstract][Full Text] [Related]
15. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
[TBL] [Abstract][Full Text] [Related]
16. [Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: when should treatment be resumed?].
Alboni P; Stucci N; Zoli G
G Ital Cardiol (Rome); 2019 Jun; 20(6):367-373. PubMed ID: 31184323
[TBL] [Abstract][Full Text] [Related]
17. The effects of anticoagulant therapy re-initiation after gastrointestinal bleeding: A systematic review and meta-analysis.
Bingzheng X; Jingnan R; Ligang B; Jianping C
J Clin Pharm Ther; 2021 Dec; 46(6):1509-1518. PubMed ID: 34101229
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
Linkins LA; Choi PT; Douketis JD
Ann Intern Med; 2003 Dec; 139(11):893-900. PubMed ID: 14644891
[TBL] [Abstract][Full Text] [Related]
19. What to do after the bleed: resuming anticoagulation after major bleeding.
Witt DM
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):620-624. PubMed ID: 27913537
[TBL] [Abstract][Full Text] [Related]
20. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
